119th Congress · introduced in the House · Jun 8, 2026
Prior Authorization Reform for Autoimmune and Blood Disorders Act
Official title from Congress.gov
Latest action (Jun 8, 2026): Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
View on Congress.govPolicy area: Health
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 23, 2026.
5 citations.
AMERICAN MEDICAL ASSOCIATION · lobbying firm or registrant: AMERICAN MEDICAL ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Health Issues
$4,540,000
Spent on own lobbying
…rs Act of 2026, all provisions H.R.7884 - Healthcare is Human Act of 2026, all provisions H.R.8794 - FED UP with Bleeding Disorders Act of 2026, all provisions H.R.9192 - Prior Authorization Reform for Autoimmune and Blood Disorders Act, all provisions H.R.929 - Dr. Lorna Breen Health Care Provider Protection Reauthorization A…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY · lobbying firm or registrant: SUMMIT HEALTH CARE CONSULTING
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 21, 2026 · issue area: Health Issues
$30,000
Paid to lobbying firm
Oppose the Patients Deserve Price Tags Act (S. 2355), specifically Section 5. Support the Prior Authorization Reform for Autoimmune and Blood Disorders Act (H.R. 9192) which applies to ERISA / self-funded plans. Requires health plans to honor prior authorization for autoimmune and blood disorder treatments for a 12-month per…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION · lobbying firm or registrant: SUMMIT HEALTH CARE CONSULTING
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 21, 2026 · issue area: Health Issues
$25,500
Paid to lobbying firm
Support the Medical Foods and Formulas Access Act (H.R. 5684, S.3304) Support the Prior Authorization Reform for Autoimmune and Blood Disorders Act (H.R. 9192) which applies to ERISA / self-funded plans. Requires health plans to honor prior authorization for autoimmune and blood disorder treatments for a 12-month per…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · lobbying firm or registrant: SUMMIT HEALTH CARE CONSULTING
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 21, 2026 · issue area: Health Issues
$21,600
Paid to lobbying firm
Support the Prior Authorization Reform for Autoimmune and Blood Disorders Act (H.R. 9192), which applies to ERISA / self-funded plans. Requires health plans to honor prior authorization for autoimmune and blood disorder treatments for a 12-month pe…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN MEDICAL ASSOCIATION · lobbying firm or registrant: AMERICAN MEDICAL ASSOCIATION
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · amended · posted Jul 20, 2026 · issue area: Health Issues
$5,130,000
Spent on own lobbying
…- No Surprises Act Enforcement Act, all provisions H.R.3170 - Improving Access to Workers Compensation for Injured Federal Workers Act of 2025, all provisions H.R.9192 - Prior Authorization Reform for Autoimmune and Blood Disorders Act, all provisions H.R.9396 - Prior Authorization Accountability Act, all provisions H.R.7884…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing